widely available is coming from investors in BioCryst, including Kleiner Perkins Caufield & Byers, the prominent Silicon Valley venture capital firm. John Doerr, the companys technology guru, was in Washington this week making the case for greater...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to New Drug for H1N1 Flu Offers Hope
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account